FDA Inspection 637086 — K.C. Pharmaceuticals, Inc.

K.C. Pharmaceuticals, Inc. — FEI 2026940

The FDA completed an inspection of K.C. Pharmaceuticals, Inc. on Dec 30, 2009 in Pomona, CA. The inspection was classified OAI (Official Action Indicated — regulatory and/or administrative actions are recommended). 11 citations were issued during this inspection. Product area: Devices.

Inspection details

Classification
Official Action Indicated (OAI)
End Date
Dec 30, 2009
Fiscal Year
2010
Product Type
Devices
Project Area
Compliance: Devices
Location
Pomona, CA (United States)

Citations

IDCFRDescription
117721 CFR 211.63Equipment Design, Size and Location
143421 CFR 211.42(c)(10)(iv)Environmental Monitoring System
145221 CFR 211.113(b)Validation lacking for sterile drug products
181021 CFR 211.160(a)Lab controls established, including changes
197521 CFR 211.182Written records kept in individual logs
202821 CFR 211.192Extent of discrepancy, failure investigations
203321 CFR 211.194(c)Testing and standardization of standards et. al.
330121 CFR 820.100(a)(2)Investigation procedures
361421 CFR 211.160(b)(4)Written calibration procedures
440221 CFR 211.192Written record of investigation incomplete
54621 CFR 820.75(a)Lack of or inadequate process validation

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.